Dr Benedict Evans
Investment Director

Ben’s healthcare experience is wide-ranging. He started his career as a physician, practising in the NHS for five years before transitioning to management consulting with McKinsey and Company, where he worked in the Firm’s healthcare practice first in London, and subsequently in the United States. He has been an operator in a number of early stage ventures spanning medical devices, enterprise analytics and healthcare IT. More recently he worked as Associate Director of Transformation at St. George’s Hospital NHS Foundation Trust.

Ben studied medicine at University College Medical School, London and is a member of the Royal College of Surgeons of England.



Richard Bradford
CEO, InHealth Group

Richard has a background in leading businesses which provide solutions and services to both private and public sectors. He began his career in logistics and facilities management working with Exel Logistics (now part of DHL).

More recently, Richard spent an eleven year period as Chief Executive of Carlisle Group, leading the group through an AIM market listing and a subsequent merger to create Impellam Group. Richard is also deputy chairman of the NHS Partners Network and a non-executive director at Gattaca plc (GATC).



Russ Cummings
Venture Partner

Russ has over 30 years of cross-sector experience as a venture capital and private equity investor. He spent 16 years at 3i Group during a period when it grew from a UK company, to a global investor spanning continental Europe, US and Asia. Highlights included investments in Sophos (LON:SOPH), Queensgate Instruments (acquired by SDL $210m), Content Technologies (acquired by Baltimore $1bn) and Oxford Asymmetry (acquired by Evotec £316m). He subsequently joined Scottish Equity Partners to launch and head up its London office. Successful investments included Searchspace (acquired by Warburg Pincus $140m) and Zeus Technology (acquired by Riverbed $140m). More recently, Russ was CEO of Touchstone Innovations plc, helping build Touchstone into an internationally recognised leader in providing patient capital to high growth businesses.

Russ is currently a Non-Executive Director on the board of British Patient Capital Ltd, a subsidiary of the British Business Bank, and Circassia Pharmaceuticals plc.